Patented Medicine Prices Review Board annual report : H78
An independent, quasi-judicial body, Canada’s Patented Medicine Prices Review Board (PMPRB) regulates the prices of prescription and non-prescription patented drugs for human and veterinary use, ensuring that these prices are not excessive. This report includes a review of the PMPRB’s major activities, as well as analyses of the prices of patented medicines and of the price trends of all drugs. It also lists the R&D expenditures reported by patent-holding drug manufacturers.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.512094&sl=1
Ministère/Organisme | Canada. Patented Medicine Prices Review Board. |
---|---|
Titre | Patented Medicine Prices Review Board annual report |
Type de publication | Série |
Langue | Bilingue-[Anglais | Français] |
Format | Papier |
Autres formats offerts | Électronique-[Anglais] |
Information sur la publication | Ottawa - Ontario : Patented Medicine Prices Review Board |
Chronologie | 1989-- |
Périodicité | Annual |
ISSN | 0847-4397 |
Numéro de catalogue |
|
Descripteurs | Drugs Prices |
Numéros | 2010: 2009: |